ALKYNYL-(HETEROARYL)-CARBOXAMIDE HCN1 INHIBITORS

The present invention provides compounds of formula Iwherein R1, R2 or R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the compounds of formula I, pharmaceutical compositions comprising them and their use as medicaments..

Medienart:

Patent

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Europäisches Patentamt - (2022) vom: 12. Okt. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

BARTELS BJOERN [VerfasserIn]
DUPONT AMANDA LEE [VerfasserIn]
HALL BENJAMIN J [VerfasserIn]
WACH JEAN-YVES [VerfasserIn]
SCHNIDER CHRISTIAN [VerfasserIn]
SCHNIDER PATRICK [VerfasserIn]
REUTLINGER MICHAEL [VerfasserIn]
O`CONNOR EOIN [VerfasserIn]
HARDE EVA KATRIN [VerfasserIn]
WEBER MICHAEL [VerfasserIn]
HIERL MARKUS [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2022-10-12, Last update posted on www.tib.eu: 2023-05-22, Last updated: 2023-06-06

Patentnummer:

EP4069685

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA015511812